Consolidated Statements of Earnings (Losses) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Income Statement [Abstract]
Net revenues	$ 26,013	$ 26,153	$ 25,110
Cost of sales	7,119	7,818	7,085
Excise taxes on products	4,902	5,312	5,314
Gross profit	13,992	13,023	12,711
Marketing, administration and research costs	2,432	2,154	2,226
Asset impairment and exit costs	0	(4)	159
Operating income	11,560	10,873	10,326
Interest and other debt expense, net	1,162	1,209	1,280
Net periodic benefit income, excluding service cost	(202)	(77)	(37)
Loss on early extinguishment of debt	649	0	0
(Income) losses from equity investments	5,979	111	(1,725)
Impairment of JUUL equity securities	0	2,600	8,600
Loss on Cronos-related financial instruments	148	140	1,442
Earnings before income taxes	3,824	6,890	766
Provision for income taxes	1,349	2,436	2,064
Net earnings (losses)	2,475	4,454	(1,298)
Net losses attributable to noncontrolling interests	0	13	5
Net earnings (losses) attributable to Altria	$ 2,475	$ 4,467	$ (1,293)
Per share data:
Basic earnings (losses) per share attributable to Altria (in usd per share)	$ 1.34	$ 2.40	$ (0.70)
Diluted earnings (losses) per share attributable to Altria (in usd per share)	$ 1.34	$ 2.40	$ (0.70)